Suppr超能文献

198金颗粒在口腔癌中的应用。

Application of 198Au grains for carcinoma of oral cavity.

作者信息

Shimizutani K, Koseki Y, Inoue T, Teshima T, Furukawa S, Kubo K, Fuchihata H, Masaki N, Ikeda H, Tanaka Y

机构信息

Department of Oral Radiology, Osaka Dental University, Japan.

出版信息

Strahlenther Onkol. 1995 Jan;171(1):29-34.

PMID:7839302
Abstract

PURPOSE

The purpose of this study is to analyze the results of the treatment using gold grain implants over the past 9 years and to evaluate the usefulness of this treatment method.

PATIENTS AND METHODS

From January 1985 through April 1993, a total of 45 patients with squamous cell carcinomas of the oral cavity and the oropharynx were treated with 198Au grain (gold grain) at the Department of Radiology, Osaka University Medical School. The initial activity of the grains supplied weekly by the Japan Radioisotope Association was usually 5 mCi (185 MBq), and single implants were usual. In case of combined external irradiation, telecobalt gamma-rays or 4 MV X-rays were used for treatment before implant.

RESULTS

The local control rate for patients with T1 stages was 80% (20/25) and with T2 stages, 59% (10/17). The local control rate was 71% (10/14) for gold grain alone and 72% (13/18) for external irradiation combined with gold grain implants (combined therapy). In combined therapy, the median of the interval between external irradiation and gold grain implants was 21 days. The treatment interval for patients with recurrent diseases was 22 days, 22, 27, 39 and 46, respectively. The progression rate showed a tendency to increase in the patients with longer interval (more than 21 days), and with partial regression after external irradiation (p = 0.0085).

CONCLUSION

Our findings show that the time interval between external irradiation and gold grain implantation is an important factor in combined therapy. Therefore, we emphasize that the time interval should be shorter than 3 weeks.

摘要

目的

本研究旨在分析过去9年使用金颗粒植入物治疗的结果,并评估这种治疗方法的有效性。

患者与方法

1985年1月至1993年4月,大阪大学医学院放射科共对45例口腔和口咽鳞状细胞癌患者采用198Au颗粒(金颗粒)进行治疗。由日本放射性同位素协会每周提供的颗粒初始活度通常为5毫居里(185兆贝可),通常采用单次植入。在联合外照射的情况下,植入前使用远距离钴γ射线或4兆伏X射线进行治疗。

结果

T1期患者的局部控制率为80%(20/25),T2期患者为59%(10/17)。单纯金颗粒治疗的局部控制率为71%(10/14),外照射联合金颗粒植入(联合治疗)的局部控制率为72%(13/18)。在联合治疗中,外照射与金颗粒植入之间的间隔中位数为21天。复发病例患者的治疗间隔分别为22天、22天、27天、39天和46天。间隔时间较长(超过21天)且外照射后有部分消退的患者,其进展率呈上升趋势(p = 0.0085)。

结论

我们的研究结果表明,外照射与金颗粒植入之间的时间间隔是联合治疗中的一个重要因素。因此,我们强调该时间间隔应短于3周。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验